Newly diagnosed patients with cirrhosis of the liver but no history ... upper gastrointestinal endoscopy for assessment of esophageal and gastric varices. If esophageal varices were present ...

its relation to ammonia intoxication is most clearly defined in patients with cirrhosis of the liver and bleeding esophageal varices. Finally, many aspects of the regimen for the treatment of ...

Esophageal capsule endoscopy for screening and surveillance of esophageal varices in patients with portal hypertension. Hepatology 47 , 1595–1603 (2008). Article Google Scholar ...

In view of his existing infectious conditions, hepatic cirrhosis was suspected as the cause of his bleeding from esophageal varices. He had also, however, been treated for a long time with ...

In view of his existing infectious conditions, hepatic cirrhosis was suspected as the cause of his bleeding from esophageal varices. He had also, however, been treated for a long time with ...

Gastric varices are present at the time of screening endoscopy in approximately 25% of patients with known cirrhosis; 18% of patients with known cirrhosis have both esophageal and gastric varices.

Because the present method is easy to perform and causes less pain to patients compared to endoscopy, it is useful for following and assessing esophageal varices in patients with liver cirrhosis.

Cirrhosis is a progressive liver condition that often remains hidden in its early stages. The disease, marked by irreversible ...

Patient population for the NAVIGATE trial is based on non-invasive tests and clinical criteria utilizing latest treatment guidelines for portal ...

Galectin Therapeutics (GALT) announced the presentation of three posters on the ongoing NAVIGATE trial in patients with MASH cirrhosis and ...

Researchers at the Medical University of South Carolina revealed the need to clarify current treatment guidelines for ...